Peer Review History
| Original SubmissionDecember 20, 2025 |
|---|
|
Dear Dr. de la Cruz-Ku, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 12 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.... We look forward to receiving your revised manuscript. Kind regards, Shekhar Gogna Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “The study was funded by the authors, and no financial support was received from any financial institution or external entity.” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The author(s) received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: I personally liked the paper a lot, well written and I would like to congratulate you all. The Reviewer 1 has raised some minor issue and i would appreciate if you all can address that. I don't necessarily agree with reviewer 2. Reviewer 3 has accidently put in the review for some random unrelated manuscript we will try and fix that. But I don't want to delay this further and once the minor revisions are done, we can move forward. Again, great job ! [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: I would like to congratulate the authors on conducting this important nationwide analysis of complex ventral hernia using the NSQIP. This dataset is one of the largest surgical databases and represents patients within the US. Even though the authors have done a commendable job in assembling and analyzing a large cohort, I have a few questions, methodological clarifications, and suggestions. Addressing these would help strengthen the manuscript’s clarity, reproducibility, and interpretability, thereby improving its value to the readership. Methods: 1. Does CPT code 15734 specify posterior or anterior component separation? This distinction is important because anterior component separation is associated with a higher complication rate than posterior component separation, and a robotic approach inherently involves only posterior component separation. 2. Does the ICD-10 code of K43.9 include patient with incisional or spontaneous ventral hernias? Did the author consider using ICD-10 code of K43.2 (Incisional hernia)? 3. In the Definition of variables and classification of cohorts” paragraph, author stated, “Patients were categorized into two cohorts based on the surgical approach: standard open ventral hernia repair versus ventral hernia repair with component separation (open or laparoscopic)” Does the author mean open vs robotic or laparoscopic? 4. Is there a variable in NSQIP to determine whether the procedure was done robotic or laparoscopic. CPT code of 49659 is classified as "unlisted laparoscopy procedure. 5. Under statistical analysis section, the author stated Patients were matched on age, sex, smoking status, body mass index, diabetes mellitus, and serum albumin level. Based on Table. 1, BMI was statistically different between the two groups. Please correct the statement. Results: 1. Under results section, the author stated “after propensity score matching, which achieved balance across age, albumin, BMI, diabetes mellitus, sex, and smoking status, robotic surgery remained strongly associated with reduced complications (Figure 1)”. The BMI was different in both groups based on Table 1. Conclusions: 1. The authors concluded that “robotic component separation for complex ventral hernia repair was associated with lower postoperative complication rates, shorter hospital stays, and fewer readmissions compared with the open approach. I would recommend removing the term complex, as NSQIP does not include a hernia size variable, unless the indication for component separation itself is being used to define complexity. Reviewer #2: The authors present an interesting topic analyzing the ACS-NSQIP database to look at robotic vs open component separation techniques. They found that the robotic technique has significantly improved postoperative outcomes vs open. The main limitation of this study is the same with any large database set which is that this data is not granular enough to draw clinically relevant conclusions. The main outcome that needs to be studied with this study is recurrence rate of hernia between the two techniques. If the immediate perioperative outcomes of the open technique are inferior but the hernia recurrence rates and hernia related complication rates are lower, this would help surgeons make a much more informed decision regarding surgical technique choice. Subgroup analysis of the different meshes used vs no mesh, and the location of mesh would greatly improve the power of this study. What about the economic costs of buying/utilizing robotic equipment vs. open? Reviewer #3: I read with interest your study entitled “Clinical Outcomes in Preemptive versus Non-preemptive Simultaneous Pancreas–Kidney Transplant Recipients: A Systematic Review and Meta-analysis.” This systematic review and meta-analysis includes seven retrospective comparative studies evaluating preemptive simultaneous pancreas–kidney transplantation (pSPKT) versus non-preemptive simultaneous pancreas–kidney transplantation (nSPKT). The authors report that pSPKT is associated with superior long-term patient survival and kidney graft survival compared with nSPKT. Overall, the study is well structured and clearly written. The methodology appears sound, and the focused results are reported appropriately. The novelty of the study is acceptable; however, the clinical message warrants further scrutiny. The main concern is that the compared groups may not be truly comparable. It is possible that patients undergoing pSPKT received kidneys from living donors, as achieving SPKT in a preemptive setting without a living donor is often challenging. This factor alone could largely explain the observed differences in outcomes and therefore should be discussed in detail. Furthermore, although some results reach statistical significance, the clinical relevance of these differences appears limited, as the reported risk ratios are very similar between groups. This issue should also be discussed more thoroughly, particularly in the context of the ongoing organ shortage in many countries, where patients may remain on waiting lists for pancreas–kidney transplantation for years without ever receiving the needed organs. Minor comments: Abstract: Results should be reported in a neutral manner. The use of terms such as “slightly better” when results favor nSPKT, versus “significantly higher” or “favored pSPKT” when results favor pSPKT, is inconsistent—especially since the risk ratios and 95% confidence intervals are in a similar range. Discussion: The following sentence is unclear and requires clarification regarding the comparison being made: “For example, pretransplant dialysis of more than 1 year was associated with a substantially higher mortality risk in SPKT patients with T2DM than in those with T1DM (a 160% vs. 59% higher risk, respectively) compared to those who underwent SPKT in a preemptive setting.” It is not clear whether this comparison refers to T1DM versus T2DM, or preemptive versus non-preemptive SPKT, and this should be explicitly clarified. ********** what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..--> Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Sepehr Abbasi DezfouliSepehr Abbasi DezfouliSepehr Abbasi DezfouliSepehr Abbasi Dezfouli ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Robotic versus Open Component Separation: A Retrospective Cohort and Propensity Score Analysis of Complication Rates and Clinical Outcomes PONE-D-25-66542R1 Dear Dr. Cruz Ku, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.... If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Shekhar Gogna Academic Editor PLOS One |
| Formally Accepted |
|
PONE-D-25-66542R1 PLOS One Dear Dr. De la Cruz Ku, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Shekhar Gogna Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .